Challenges and opportunities for stem cell therapy in patients with chronic kidney disease

Kidney International

Volumn 89, Issue 4, 2016, Pages 767-778

  Hickson, Latonya J ^a   Eirin, Alfonso ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

end stage renal disease; senescence; stem cells; uremia

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; UBIDECARENONE; UREMIC TOXIN;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; END STAGE RENAL DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; HUMAN; IMMUNOMODULATION; KIDNEY TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; UREMIA; RENAL INSUFFICIENCY, CHRONIC; TRANSPLANTATION;

ENDOTHELIAL PROGENITOR CELLS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; RENAL INSUFFICIENCY, CHRONIC;

EID: 84964661462     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2015.11.023     Document Type: Review

References (177)

1. V. Jha, G. Garcia-Garcia, K. Iseki, and et al. Chronic kidney disease: global dimension and perspectives Lancet 382 2013 260 272
2. US Renal Data System Chapter 1: CKD in the general population. 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States 2014 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda, MD
3. L.J. Hickson, F.G. Cosio, Z.M. El-Zoghby, and et al. Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T Am J Transplant 8 2008 2352 2359
4. L.J. Hickson, Z.M. El-Zoghby, E.C. Lorenz, and et al. Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels Am J Transplant 9 2009 1354 1361
5. K.L. Schoonover, L.J. Hickson, S.M. Norby, and et al. Risk factors for hospitalization among older, incident haemodialysis patients Nephrology (Carlton) 18 2013 712 717
6. US Renal Data System Volume 2: ESRD in the United States: an overview of USRDS Annual Data Report. 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States 2014 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda, MD
7. R.N. Foley, S.C. Chen, C.A. Solid, and et al. Early mortality in patients starting dialysis appears to go unregistered Kidney Int 86 2014 392 398
8. B.D. Bradbury, R.B. Fissell, J.M. Albert, and et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Clin J Am Soc Nephrol 2 2007 89 99
9. 2020: A new vision - a future for regenerative medicine 2006 US Department of Health and Human Services Washington, DC
10. J. Tan, W. Wu, X. Xu, and et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial JAMA 307 2012 1169 1177
11. C. Westenfelder, and F.E. Togel Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials Kidney Int Suppl (2011) 1 2011 103 106
12. Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease. ClinicalTrials.gov, a service of the US National Institutes of Health; 2014.
13. Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD). ClinicalTrials.gov, a service of the US National Institutes of Health; 2014.
14. Y. Peng, M. Ke, L. Xu, and et al. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study Transplantation 95 2013 161 168
15. A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects (ACT-AKI). ClinicalTrials.gov, a service of the US National Institutes of Health; 2014.
16. American Society of Nephrology. ASN Kidney Week 2014 News Release: High impact clinical trials yield results that could lead to improved kidney care. 2014. Available at: http://www.pkdcure.org/file/news/documents/ASN-KW14-High-Impact-Clinical - Trials-102014-R2.pdf. Accessed August 20, 2015.
17. A.R. Chade, X. Zhu, R. Lavi, and et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease Circulation 119 2009 547 557
18. Y. Fang, X. Tian, S. Bai, and et al. Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway Int J Mol Med 30 2012 85 92
19. X.Y. Zhu, V. Urbieta-Caceres, J.D. Krier, and et al. Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms Stem Cells 31 2013 117 125
20. D.A. Papazova, N.R. Oosterhuis, H. Gremmels, and et al. Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis Dis Model Mech 8 2015 281 293
21. S.R. Lee, S.H. Lee, J.Y. Moon, and et al. Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model Ren Fail 32 2010 840 848
22. A. van Koppen, J.A. Joles, L.G. Bongartz, and et al. Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease Cell Transplant 21 2012 2299 2312
23. A. van Koppen, J.A. Joles, B.W. van Balkom, and et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease PLoS One 7 2012 e38746
24. D. Li, N. Wang, L. Zhang, and et al. Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor Stem Cell Res Ther 4 2013 103
25. R.C. Castiglione, T. Maron-Gutierrez, C.M. Barbosa, and et al. Bone marrow-derived mononuclear cells promote improvement in glomerular function in rats with early diabetic nephropathy Cell Physiol Biochem 32 2013 699 718
26. F. Ezquer, M. Ezquer, V. Simon, and et al. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice Biol Blood Marrow Transplant 15 2009 1354 1365
27. A. Eirin, X.Y. Zhu, B. Ebrahimi, and et al. Intra-renal delivery of mesenchymal stem cells and endothelial progenitor cells attenuates hypertensive cardiomyopathy in experimental renovascular hypertension Cell Transplant 24 2015 2041 2053
28. A. Eirin, X.Y. Zhu, J.D. Krier, and et al. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis Stem Cells 30 2012 1030 1041
29. A. Borodkina, A. Shatrova, P. Abushik, and et al. Interaction between ROS dependent DNA damage, mitochondria and p38 MAPK underlies senescence of human adult stem cells Aging 6 2014 481 495
30. J. Chen, and M.S. Goligorsky Premature senescence of endothelial cells: Methusaleh's dilemma Am J Physiol Heart Circ Physiol 290 2006 H1729 H1739
31. Y. Zhu, J.L. Armstrong, T. Tchkonia, and et al. Cellular senescence and the senescent secretory phenotype in age-related chronic diseases Curr Opin Clin Nutr Metab Care 17 2014 324 328
32. J. Hoffmann, J. Haendeler, A. Aicher, and et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide Circ Res 89 2001 709 715
33. T. Tchkonia, D.E. Morbeck, T. Von Zglinicki, and et al. Fat tissue, aging, and cellular senescence Aging Cell 9 2010 667 684
34. J.F. Passos, G. Nelson, C. Wang, and et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence Mol Syst Biol 6 2010 347
35. T. Tchkonia, Y. Zhu, J. van Deursen, and et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities J Clin Invest 123 2013 966 972
36. T. Asahara, T. Murohara, A. Sullivan, and et al. Isolation of putative progenitor endothelial cells for angiogenesis Science 275 1997 964 967
37. C. Urbich, A. Aicher, C. Heeschen, and et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells J Mol Cell Cardiol 39 2005 733 742
38. M. Peichev, A.J. Naiyer, D. Pereira, and et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors Blood 95 2000 952 958
39. P.E. Szmitko, P.W. Fedak, R.D. Weisel, and et al. Endothelial progenitor cells: new hope for a broken heart Circulation 107 2003 3093 3100
40. K. Herbrig, F. Pistrosch, S. Foerster, and et al. Endothelial progenitor cells in chronic renal insufficiency Kidney Blood Press Res 29 2006 24 31
41. G. Nowak, A. Karrar, C. Holmen, and et al. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization Circulation 110 2004 3699 3707
42. N. Werner, S. Kosiol, T. Schiegl, and et al. Circulating endothelial progenitor cells and cardiovascular outcomes N Engl J Med 353 2005 999 1007
43. J.M. Hill, G. Zalos, J.P. Halcox, and et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 2003 593 600
44. M. Vasa, S. Fichtlscherer, A. Aicher, and et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ Res 89 2001 E1 E7
45. Y.T. Chen, B.C. Cheng, S.F. Ko, and et al. Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease Clin Exp Nephrol 17 2013 83 91
46. H. Ueno, H. Koyama, S. Fukumoto, and et al. Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease Metabolism 60 2011 453 459
47. J. Zhao, E.M. Bolton, L. Randle, and et al. Functional characterization of late outgrowth endothelial progenitor cells in patients with end-stage renal failure Transpl Int 27 2014 437 451
48. C.T. Chan, S.H. Li, and S. Verma Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease Am J Physiol Renal Physiol 289 2005 F679 F684
49. A. Eirin, X.Y. Zhu, Z. Li, and et al. Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis Arterioscler Thromb Vasc Biol 33 2013 1006 1013
50. O. Kwon, S. Miller, N. Li, and et al. Bone marrow-derived endothelial progenitor cells and endothelial cells may contribute to endothelial repair in the kidney immediately after ischemia-reperfusion J Histochem Cytochem 58 2010 687 694
51. D. Patschan, K. Krupincza, S. Patschan, and et al. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning Am J Physiol Renal Physiol 291 2006 F176 F185
52. A.R. Chade, X.Y. Zhu, J.D. Krier, and et al. Endothelial progenitor cells homing and renal repair in experimental renovascular disease Stem Cells 28 2010 1039 1047
53. B. Ebrahimi, Z. Li, A. Eirin, and et al. Addition of endothelial progenitor cells to renal revascularization restores medullary tubular oxygen consumption in swine renal artery stenosis Am J Physiol Renal Physiol 302 2012 F1478 F1485
54. A.J. Friedenstein, R.K. Chailakhyan, N.V. Latsinik, and et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo Transplantation 17 1974 331 340
55. A.J. Friedenstein, U.F. Deriglasova, N.N. Kulagina, and et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method Exp Hematol 2 1974 83 92
56. H. Asanuma, D.R. Meldrum, and K.K. Meldrum Therapeutic applications of mesenchymal stem cells to repair kidney injury J Urol 184 2010 26 33
57. M. Dominici, K. Le Blanc, I. Mueller, and et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
58. A. Eirin, S.M. Riester, X.Y. Zhu, and et al. MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells Gene 551 2014 55 64
59. F. Collino, S. Bruno, D. Incarnato, and et al. AKI recovery induced by mesenchymal stromal cell-derived extracellular vesicles carrying microRNAs J Am Soc Nephrol 26 2015 2349 2360
60. A. Eirin, X. Zhang, X.Y. Zhu, and et al. Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis Nephrol Dial Transplant 29 2014 274 282
61. K. Gao, Y. Chen, L. Wei, and et al. Inhibitory effect of mesenchymal stem cells on lymphocyte proliferation Cell Biochem Funct 26 2008 900 907
62. K. Le Blanc, and O. Ringden Immunomodulation by mesenchymal stem cells and clinical experience J Intern Med 262 2007 509 525
63. A. Eirin, and L.O. Lerman Mesenchymal stem cell treatment for chronic renal failure Stem Cell Res Ther 5 2014 83
64. F.E. Ezquer, M.E. Ezquer, D.B. Parrau, and et al. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice Biol Blood Marrow Transplant 14 2008 631 640
65. S. Choi, M. Park, J. Kim, and et al. The role of mesenchymal stem cells in the functional improvement of chronic renal failure Stem Cells Dev 18 2009 521 529
66. M. Franquesa, E. Herrero, J. Torras, and et al. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model Stem Cells Dev 21 2012 3125 3135
67. B. Ebrahimi, A. Eirin, Z. Li, and et al. Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis PLoS One 8 2013 e67474
68. A. Eirin, X.Y. Zhu, C.M. Ferguson, and et al. Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease Stem Cell Res Ther 6 2015 7
69. A.B. Mathiasen, M. Haack-Sorensen, and J. Kastrup Mesenchymal stromal cells for cardiovascular repair: current status and future challenges Future Cardiol 5 2009 605 617
70. K. Herbrig, F. Pistrosch, U. Oelschlaegel, and et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis Am J Kidney Dis 44 2004 840 849
71. F.H. Bahlmann, K. DeGroot, T. Duckert, and et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Kidney Int 64 2003 1648 1652
72. J.H. Choi, K.L. Kim, W. Huh, and et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure Arterioscler Thromb Vasc Biol 24 2004 1246 1252
73. K. de Groot, F.H. Bahlmann, E. Bahlmann, and et al. Kidney graft function determines endothelial progenitor cell number in renal transplant recipients Transplantation 79 2005 941 945
74. K. de Groot, F.H. Bahlmann, J. Sowa, and et al. Uremia causes endothelial progenitor cell deficiency Kidney Int 66 2004 641 646
75. T. Eizawa, Y. Murakami, K. Matsui, and et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients Curr Med Res Opin 19 2003 627 633
76. K.E. Jie, M.R. Lilien, M.H. Goossens, and et al. Reduced endothelial progenitor cells in children with hemodialysis but not predialysis chronic kidney disease Pediatrics 126 2010 e990 e993
77. K.E. Jie, M.A. Zaikova, M.W. Bergevoet, and et al. Progenitor cells and vascular function are impaired in patients with chronic kidney disease Nephrol Dial Transplant 25 2010 1875 1882
78. N. Jourde-Chiche, L. Dou, F. Sabatier, and et al. Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients J Thromb Haemost 7 2009 1576 1584
79. K. Kohagura, Y. Ohya, S. Miyagi, and et al. rHuEPO dose inversely correlated with the number of circulating CD34+ cells in maintenance hemodialysis patients Nephron Clin Pract 108 2008 c41 c46
80. G. Krenning, P.Y. Dankers, J.W. Drouven, and et al. Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease Am J Physiol Renal Physiol 296 2009 F1314 F1322
81. D.H. Krieter, R. Fischer, K. Merget, and et al. Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapy Nephrol Dial Transplant 25 2010 4023 4031
82. S. Maruyama, A. Taguchi, S. Iwashima, and et al. Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients Kidney Int 74 2008 1603 1609
83. G. Schlieper, M. Hristov, V. Brandenburg, and et al. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients Nephrol Dial Transplant 23 2008 2611 2618
84. H. Ueno, H. Koyama, S. Fukumoto, and et al. Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients Nephrol Dial Transplant 25 2010 581 586
85. P.E. Westerweel, I.E. Hoefer, P.J. Blankestijn, and et al. End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells Am J Physiol Renal Physiol 292 2007 F1132 F1140
86. M.S. Goligorsky, K. Yasuda, and B. Ratliff Dysfunctional endothelial progenitor cells in chronic kidney disease J Am Soc Nephrol 21 2010 911 919
87. S. Steiner, G. Schaller, H. Puttinger, and et al. History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients Am J Kidney Dis 46 2005 520 528
88. K. Herbrig, K. Gebler, U. Oelschlaegel, and et al. Kidney transplantation substantially improves endothelial progenitor cell dysfunction in patients with end-stage renal disease Am J Transplant 6 2006 2922 2928
89. F.H. Bahlmann, K. De Groot, J.M. Spandau, and et al. Erythropoietin regulates endothelial progenitor cells Blood 103 2004 921 926
90. M. Roemeling-van Rhijn, M.E. Reinders, A. de Klein, and et al. Mesenchymal stem cells derived from adipose tissue are not affected by renal disease Kidney Int 82 2012 748 758
91. M.E. Reinders, M. Roemeling-van Rhijn, M. Khairoun, and et al. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy Cytotherapy 15 2013 663 672
92. S. Yamanaka, S. Yokote, A. Yamada, and et al. Adipose tissue-derived mesenchymal stem cells in long-term dialysis patients display downregulation of PCAF expression and poor angiogenesis activation PLoS One 9 2014 e102311
93. B.M. Klinkhammer, R. Kramann, M. Mallau, and et al. Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential PLoS One 9 2014 e92115
94. H. Noh, M.R. Yu, H.J. Kim, and et al. Uremia induces functional incompetence of bone marrow-derived stromal cells Nephrol Dial Transplant 27 2012 218 225
95. A. Eirin, M.L. Gloviczki, H. Tang, and et al. Inflammatory and injury signals released from the post-stenotic human kidney Eur Heart J 34 2013 540 548a
96. C. Heeschen, A. Aicher, R. Lehmann, and et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization Blood 102 2003 1340 1346
97. H. Miyazaki, H. Matsuoka, H. Itabe, and et al. Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer Circulation 101 2000 1002 1006
98. F. Stam, C. van Guldener, A. Becker, and et al. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study J Am Soc Nephrol 17 2006 537 545
99. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
100. A.J. Flammer, M. Gossl, R.J. Widmer, and et al. Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis Eur Heart J 33 2012 2963 2969
101. M. Gossl, S. Khosla, X. Zhang, and et al. Role of circulating osteogenic progenitor cells in calcific aortic stenosis J Am Coll Cardiol 60 2012 1945 1953
102. M. Gossl, U.I. Modder, R. Gulati, and et al. Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells Eur Heart J 31 2010 2909 2914
103. Y.H. Chen, S.J. Lin, F.Y. Lin, and et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms Diabetes 56 2007 1559 1568
104. P. Brunet, B. Gondouin, A. Duval-Sabatier, and et al. Does uremia cause vascular dysfunction? Kidney Blood Press Res 34 2011 284 290
105. A. Popolo, G. Autore, A. Pinto, and et al. Oxidative stress in patients with cardiovascular disease and chronic renal failure Free Radic Res 47 2013 346 356
106. R. Ramirez, J. Carracedo, A. Merino, and et al. Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport Kidney Int 72 2007 108 113
107. M.J. Callaghan, D.J. Ceradini, and G.C. Gurtner Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function Antioxid Redox Signal 7 2005 1476 1482
108. P. Haddad, S. Dussault, J. Groleau, and et al. Nox2-derived reactive oxygen species contribute to hypercholesterolemia-induced inhibition of neovascularization: effects on endothelial progenitor cells and mature endothelial cells Atherosclerosis 217 2011 340 349
109. E. Tuaillon, I. Jaussent, M. Morena, and et al. T-cell activation and malnutrition adversely impact on endothelial progenitor cell mobilization in patients on extracorporeal maintenance dialysis therapy Blood Purif 39 2015 313 322
110. I. Verma, A. Syngle, and P. Krishan Endothelial progenitor cell biology in ankylosing spondylitis Int J Rheum Dis 18 2015 336 340
111. A. Lo Gullo, G. Mandraffino, G. Bagnato, and et al. Vitamin D status in rheumatoid arthritis: inflammation, arterial stiffness and circulating progenitor cell number PLoS One 10 2015 e0134602
112. A. Lo Gullo, G. Mandraffino, M.A. Sardo, and et al. Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress Scand J Rheumatol 43 2014 184 193
113. W. Kuang, X. Xu, J. Lin, and et al. Functional and molecular changes of MSCs in aging Curr Stem Cell Res Ther 10 2015 384 391
114. D. Lanza, A.F. Perna, A. Oliva, and et al. Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells PLoS One 10 2015 e0116468
115. A.F. Perna, M.G. Luciano, D. Ingrosso, and et al. Hydrogen sulphide-generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes Nephrol Dial Transplant 24 2009 3756 3763
116. A. Yamada, T. Yokoo, S. Yokote, and et al. Comparison of multipotency and molecular profile of MSCs between CKD and healthy rats Hum Cell 27 2014 59 67
117. Z. Li, C. Liu, Z. Xie, and et al. Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation PLoS One 6 2011 e20526
118. H. Kim, J.W. Han, J.Y. Lee, and et al. Diabetic mesenchymal stem cells are ineffective for improving limb ischemia due to their impaired angiogenic capability Cell Transplant 24 2015 1571 1584
119. M.I. Saad, T.M. Abdelkhalek, M.M. Saleh, and et al. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells Endocrine 50 2015 537 567
120. K. Kokame, H. Kato, and T. Miyata Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes J Biol Chem 271 1996 29659 29665
121. G. Sengoelge, M. Fodinger, S. Skoupy, and et al. Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin Kidney Int 54 1998 1637 1651
122. L. Dou, E. Bertrand, C. Cerini, and et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair Kidney Int 65 2004 442 451
123. L. Dou, N. Jourde-Chiche, V. Faure, and et al. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells J Thromb Haemost 5 2007 1302 1308
124. N. Neirynck, R. Vanholder, E. Schepers, and et al. An update on uremic toxins Int Urol Nephrol 45 2013 139 150
125. N.D. Vaziri Oxidative stress in uremia: nature, mechanisms, and potential consequences Semin Nephrol 24 2004 469 473
126. C.M. Kjellstrand, U. Buoncristiani, G. Ting, and et al. Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years Nephrol Dial Transplant 23 2008 3283 3289
127. M. D'Apolito, X. Du, H. Zong, and et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure J Clin Invest 120 2010 203 213
128. G.L. Glorieux, A.W. Dhondt, P. Jacobs, and et al. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection Kidney Int 65 2004 2184 2192
129. E. Schepers, G. Glorieux, L. Dou, and et al. Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation Blood Purif 30 2010 277 287
130. S. Kiechl, T. Lee, P. Santer, and et al. Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population Atherosclerosis 205 2009 261 265
131. A. Meinitzer, U. Seelhorst, B. Wellnitz, and et al. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study) Clin Chem 53 2007 273 283
132. P. Vallance, A. Leone, A. Calver, and et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 1992 572 575
133. C. Zoccali, S. Bode-Boger, F. Mallamaci, and et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study Lancet 358 2001 2113 2117
134. E. Schepers, D.V. Barreto, S. Liabeuf, and et al. Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease Clin J Am Soc Nephrol 6 2011 2374 2383
135. S.M. Bode-Boger, F. Scalera, J.T. Kielstein, and et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease J Am Soc Nephrol 17 2006 1128 1134
136. S. Liabeuf, D.V. Barreto, F.C. Barreto, and et al. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease Nephrol Dial Transplant 25 2010 1183 1191
137. E. Schepers, N. Meert, G. Glorieux, and et al. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production Nephrol Dial Transplant 22 2007 592 596
138. J. Heinz, S. Kropf, C. Luley, and et al. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis Am J Kidney Dis 54 2009 478 489
139. X. Pang, J. Liu, J. Zhao, and et al. Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-kappaB signal pathway in rat vascular smooth muscle cells Atherosclerosis 236 2014 73 81
140. S. Yamagishi, S. Maeda, T. Matsui, and et al. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes Biochim Biophys Acta 1820 2012 663 671
141. A. Goldin, J.A. Beckman, A.M. Schmidt, and et al. Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 2006 597 605
142. E. Linden, W. Cai, J.C. He, and et al. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation Clin J Am Soc Nephrol 3 2008 691 698
143. Stinghen AE, Massy ZA, Vlassara H, et al. Uremic toxicity of advanced glycation end products in CKD [e-pub ahead of print]. J Am Soc Nephrol. doi: 10.1681/ASN.2014101047, August 26, 2015.
144. V.C. Wu, G.H. Young, P.H. Huang, and et al. In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statin Angiogenesis 16 2013 609 624
145. J.Z. Chen, J.H. Zhu, X.X. Wang, and et al. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood J Mol Cell Cardiol 36 2004 233 239
146. J. Nelson, Y. Wu, X. Jiang, and et al. Hyperhomocysteinemia suppresses bone marrow CD34+/VEGF receptor 2+ cells and inhibits progenitor cell mobilization and homing to injured vasculature - a role of beta1-integrin in progenitor cell migration and adhesion FASEB J 29 2015 3085 3099
147. Y. Ying, K. Yang, Y. Liu, and et al. A uremic solute, P-cresol, inhibits the proliferation of endothelial progenitor cells via the p38 pathway Circ J 75 2011 2252 2259
148. F. Fleissner, V. Jazbutyte, J. Fiedler, and et al. Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism Circ Res 107 2010 138 143
149. T. Thum, D. Tsikas, S. Stein, and et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine J Am Coll Cardiol 46 2005 1693 1701
150. R. Kramann, S.K. Couson, S. Neuss, and et al. Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells Arterioscler Thromb Vasc Biol 31 2011 e45 e54
151. R. Kramann, S.K. Couson, S. Neuss, and et al. Uraemia disrupts the vascular niche in a 3D co-culture system of human mesenchymal stem cells and endothelial cells Nephrol Dial Transplant 27 2012 2693 2702
152. M. Idziak, P. Pedzisz, A. Burdzinska, and et al. Uremic toxins impair human bone marrow-derived mesenchymal stem cells functionality in vitro Exp Toxicol Pathol 66 2014 187 194
153. B. Cai, X. Li, Y. Wang, and et al. Apoptosis of bone marrow mesenchymal stem cells caused by homocysteine via activating JNK signal PLoS One 8 2013 e63561
154. H. Noh, M.R. Yu, H.J. Kim, and et al. Uremic toxin p-cresol induces Akt-pathway-selective insulin resistance in bone marrow-derived mesenchymal stem cells Stem Cells 32 2014 2443 2453
155. P.S. Lee, and K.K. Poh Endothelial progenitor cells in cardiovascular diseases World J Stem Cells 6 2014 355 366
156. X.M. Bao, C.F. Wu, and G.P. Lu Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK Atherosclerosis 210 2010 114 121
157. S. Dimmeler, A. Aicher, M. Vasa, and et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway J Clin Invest 108 2001 391 397
158. U. Landmesser, N. Engberding, F.H. Bahlmann, and et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase Circulation 110 2004 1933 1939
159. B. Hibbert, T. Simard, F.D. Ramirez, and et al. The effect of statins on circulating endothelial progenitor cells in humans: a systematic review J Cardiovasc Pharmacol 62 2013 491 496
160. C. de Ciuceis, A. Pilu, D. Rizzoni, and et al. Effect of antihypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension Blood Press 20 2011 77 83
161. K. Esposito, M.I. Maiorino, C. Di Palo, and et al. Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes - a randomized controlled trial Diabetes Obes Metab 13 2011 439 445
162. C.H. Wang, M.K. Ting, S. Verma, and et al. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus Am Heart J 152 2006 1051.e1 1051.e8
163. G.P. Fadini, E. Boscaro, M. Albiero, and et al. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha Diabetes Care 33 2010 1607 1609
164. C.S. Park, W. Kim, J.S. Woo, and et al. Green tea consumption improves endothelial function but not circulating endothelial progenitor cells in patients with chronic renal failure Int J Cardiol 145 2010 261 262
165. F. Manfredini, G.M. Rigolin, A.M. Malagoni, and et al. Exercise training and endothelial progenitor cells in haemodialysis patients J Int Med Res 37 2009 534 540
166. X. Wang, C. Liu, S. Li, and et al. Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of diabetic erectile dysfunction via augmenting angiogenesis and neuroprotection PLoS One 10 2015 e0118951
167. L. Wei, J.L. Fraser, Z.Y. Lu, and et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats Neurobiol Dis 46 2012 635 645
168. S.P. Yu, Z. Wei, and L. Wei Preconditioning strategy in stem cell transplantation therapy Transl Stroke Res 4 2013 76 88
169. A. van Koppen, D.A. Papazova, N.R. Oosterhuis, and et al. Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease Stem Cell Res Ther 6 2015 63
170. S. Benvenuti, I. Cellai, P. Luciani, and et al. Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells J Endocrinol Invest 30 2007 RC26 RC30
171. D. Contador, F. Ezquer, M. Espinosa, and et al. Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells Exp Biol Med (Maywood) 240 2015 1235 1246
172. D. Zhang, B. Yan, S. Yu, and et al. Coenzyme Q10 inhibits the aging of mesenchymal stem cells induced by D-galactose through Akt/mTOR signaling Oxid Med Cell Longev 2015 2015 867293
173. Fu G, Ren A, Qiu Y, et al. Epigenetic regulation of osteogenic differentiation of mesenchymal stem cells [e-pub ahead of print]. Curr Stem Cell Res Ther. http://dx.doi.org/10.2174/1574888X10666150528153313, May 28, 2015.
174. C.M. Teven, X. Liu, N. Hu, and et al. Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation Stem Cells Int 2011 2011 201371
175. Y. Zhu, T. Tchkonia, T. Pirtskhalava, and et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs Aging Cell 14 2015 644 658
176. A. Eirin, X.Y. Zhu, J.R. Woollard, and et al. Increased circulating inflammatory endothelial cells in blacks with essential hypertension Hypertension 62 2013 585 591
177. L. da Silva Meirelles, P.C. Chagastelles, and N.B. Nardi Mesenchymal stem cells reside in virtually all post-natal organs and tissues J Cell Sci 119 2006 2204 2213